Skip to Content

M A-P 2 (Atovaquone and proguanil hydrochloride 250 mg / 100 mg)

Pill imprint M A-P 2 has been identified as Atovaquone and proguanil hydrochloride 250 mg / 100 mg.

Atovaquone/proguanil is used in the treatment of malaria prevention; malaria and belongs to the drug class antimalarial combinations. Risk cannot be ruled out during pregnancy. Atovaquone/proguanil 250 mg / 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Atovaquone and proguanil hydrochloride 250 mg / 100 mg M A-P 2 Front
Atovaquone and proguanil hydrochloride 250 mg / 100 mg M A-P 2 Back
Discount Card Promo
Atovaquone and proguanil hydrochloride
Imprint:
M A-P 2
Strength:
250 mg / 100 mg
Color:
Beige
Shape:
Round
Availability:
Prescription only
Drug Class:
Antimalarial combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide